Towards a Practical Clinical Use of Fractioned Exhaled Nitric Oxide Levels in Chronic Cough

Total Page:16

File Type:pdf, Size:1020Kb

Towards a Practical Clinical Use of Fractioned Exhaled Nitric Oxide Levels in Chronic Cough Commentary Page 1 of 4 Towards a practical clinical use of fractioned exhaled nitric oxide levels in chronic cough Patrizia Pignatti1, Antonio Spanevello2,3 1Allergy and Immunology Unit, Salvatore Maugeri Foundation, IRCCS, Pavia, Italy; 2Department of Clinical and Experimental Medicine, University of Insubria, Varese, Italy; 3Pneumology Unit, Rehabilitation Institute of Tradate, Salvatore Maugeri Foundation, IRCCS, Pavia, Italy Correspondence to: Patrizia Pignatti. Allergy and Immunology Unit, Fondazione Salvatore Maugeri, IRCCS, Via S. Maugeri, 27100 Pavia, Italy. Email: [email protected]. Submitted Jun 26, 2016. Accepted for publication Jun 28, 2016. doi: 10.21037/atm.2016.08.13 View this article at: http://dx.doi.org/10.21037/atm.2016.08.13 Fractioned exhaled nitric oxide (FeNO) is the amount of strict clinical evidence. In healthy subjects upper limits of nitric oxide (NO) present in the airways detectable of FeNO ranges from 24.0 to 54.0 ppb, depending on with chemiluminescent or electrochemical methods in age and height (6). Up to now, its main application is in the exhaled air. The exhaled NO measured is the sum of the assessment of airway inflammation, since high FeNO the constitutive gas produced by the neuronal and the levels are associated with eosinophilic inflammation in the endothelial isoforms of the NO synthases and the amount airways (7). Smoking is an important interfering factor produced after activation of the inducible isoform of this in the evaluation of FeNO, since smoking subjects have enzyme (1). The inducible isoform produces a high quantity lower FeNO levels, limiting the clinical value of FeNO of NO, nM range, compared to the constitutive isoforms, determination to non-smokers (8). which produce pM amount of the gas. The inducible Many studies, including International guidelines (5,9), isoform is mainly present in macrophages and epithelial proposed the use of FeNO to support the diagnosis of cells in the airways and it accounts for most of the FeNO asthma although, other more recent publications, concluded detected. One interesting characteristic of the inducible that FeNO sensitivity and specificity is insufficient to production of FeNO is that it is quite well down-modulated accurately diagnose asthma (10,11). by corticosteroids compared to the NO produced by the FeNO results in obese subjects are conflicting: in obese constitutive isoforms (1). adult subjects wheezing was significantly associated with From the early Nineties, when the first studies measuring reduced FeNO, whereas a positive association between FeNO in the airways of asthmatic patients were published wheezing and FeNO among the nonobese subjects was (2,3), the amount of publications in this field increased found, suggesting possible differences in FeNO levels over the years, reaching the top in 2013. Feasibility and according to asthma phenotypes based on body weight (12). noninvasiveness of FeNO determination for the evaluation In children, a positive correlation between BMI and FeNO of airway inflammation produced an increase in the number levels was reported only in nonasthmatic subjects, which of publications with different methodologies raising the suggests a link between obesity and increased airway need of standardization. An ATS and ERS recommendation inflammation independently from asthma development (13). for standardized procedures for FeNO measurements was Among asthmatic patients FeNO evaluation seems published in 2005 (4) and an ATS official clinical practice more useful to define the Th2 phenotype, characterized by guideline on interpretation of FeNO levels and clinical eosinophilic inflammation, high periostin levels and higher application in 2011 (5). probability to respond to inhaled corticosteroid therapy (10). The noninvasiveness of FeNO evaluation and the Furthermore, FeNO was measured in many other possibility to evaluate it with portable devices spread the respiratory conditions, particularly either when the diffusion of this determination from research to routine inflammatory pattern may be useful to the diagnosis or practice, opening its use sometimes even in the absence to the follow up or when the response to corticosteroid © Annals of Translational Medicine. All rights reserved. atm.amegroups.com Ann Transl Med 2016;4(18):357 Page 2 of 4 Pignatti and Spanevello. FeNO in chronic cough therapy should be assessed (14). that patients with moderate to severe asthma in whom Chronic cough is an exclusion diagnosis made in patients the therapy was adapted according to sputum eosinophils with cough which persists at least for 8 weeks (15). The count had less exacerbations than subjects managed with different causes responsible for this symptom have been standard clinical guidelines (20). Unfortunately, sputum considered in order to subgroup chronic cough in cough induction and differential cell count are available only in variant asthma, upper airway cough syndrome, eosinophilic a limited number of specialized centers and results are not bronchitis, gastroesophageal reflux-related cough and atopic immediately provided, suggesting FeNO evaluation as an cough (15). FeNO levels have been used to define asthma easier and more rapid methodology to assess eosinophilic among subjects with chronic cough (16) but again the utility inflammation. of this non-invasive methodology relies more in defining a In the last few years, many studies in asthmatic subjects, subgroup of subjects among those with chronic cough than particularly clinical trials (21), considered the percentage on the diagnosis of chronic cough itself. or the number of blood eosinophils as surrogate marker Recently, Yi et al. reported the results of a study of airway eosinophils. In the study by Yi et al. (17), such a conducted on the utility of FeNO in diagnosing subjects biomarker was not considered, even if it would have been with corticosteroid-responsive cough (CRC) (17). The interesting to evaluate its sensitivity and specificity in authors evaluated 244 patients with chronic cough and 59 predicting CRC compared to FeNO levels. healthy subjects, more than half of the patients enrolled had The study by Yi et al., presented different cut-off levels CRC; in these subjects, FeNO is higher than in patients of FeNO in patients with chronic cough, resulting in with corticosteroid non-responsive cough and significantly different sensitivity and specificity. FeNO higher than correlated with sputum eosinophils. Among chronic cough 22.5 ppb resulted in 74.6% sensitivity and 77.2% specificity patients, FeNO level of 31.5 ppb has high specificity to predict sputum eosinophils >2.5%, while with a cut-off (91.4%) but low sensitivity (54.0%) in predicting those value of 33.5 ppb the specificity was adjusted to 95%. In with CRC, with a positive predictive value of 89.3% and a the meantime, a cut-off value of 31.5 ppb has the higher negative predictive value of 60%. The combination of low specificity in discriminating CRC (17). Considering such FeNO levels, low sputum eosinophils (<2.5%) and absence small differences in cut-offs, the inter-individual variability of atopy has a sensitivity of 93.5% in predicting subjects of FeNO evaluation, as measured in each specific setting, with corticosteroid-resistance. These results, as those should always be checked. published in the asthma field (18), highlighted that the Patients enrolled in Yi’s study were non-smokers or ex- usefulness of airway inflammation evaluation through non- smokers with cessation of smoking for at least 6 months invasive markers, consists not in supporting the diagnosis before the study. Considering the decreasing effect of but in discriminating a particular subset of subjects for the smoking habit on FeNO levels (11) the application in whom a specific therapy is more useful. These results are real life of these cut-offs values should be limited to non- particularly interesting in trying to use biological markers smoking subjects. in an alternative way, which could favor its entrance in Atopy is another variable considered by Yi et al. in clinical practice. Most of the patients with chronic cough their study in order to define a cut-off level for CRC. The are prescribed inhaled corticosteroids without the evidence authors found that low FeNO levels (<22.5 ppb), normal that this approach may be the right one for the patient. sputum eosinophils (<2.5%) and absence of atopy suggested FeNO evaluation, with the proper cut-off levels, could be a lower probability of CRC (19). Many studies reported the useful to direct therapy towards personalized treatment. In association between FeNO levels and atopy with increasing this view, step-down therapy in subjects with CRC could threshold for FeNO levels in atopic asthmatic subjects both be monitored with FeNO levels and more successfully in adults (22) and in children (23). done, considered that step-down therapy is not always Yi et al., did not report in their study whether a easily practiced and discontinuation of ICS/LABA causes possible occupational cause for chronic cough had been worsening of the disease in patients with cough variant considered (17). Despite published recommendations, asthma (19). both in cough guidelines/protocols and in clinical practice, Monitoring the step down therapy through the it is quite frequent that an occupational trigger is not evaluation of airway inflammation is a strategy already contemplated among the causes of chronic cough (24,25). proposed for asthmatic patients. Green et al. reported The lack of recognition of an occupational cause of © Annals of Translational Medicine. All rights reserved. atm.amegroups.com Ann Transl Med 2016;4(18):357 Annals of Translational Medicine, Vol 4, No 18 September 2016 Page 3 of 4 chronic cough could have important consequences since Respir Crit Care Med 2005;171:912-30. it could delay preventive measures at work and could lead 5. Dweik RA, Boggs PB, Erzurum SC, et al. An official ATS to a wrong therapy prescription. FeNO evaluations in clinical practice guideline: interpretation of exhaled nitric subjects with work related cough could be useful for both oxide levels (FENO) for clinical applications.
Recommended publications
  • Laryngopharyngeal Reflux and Chronic Cough Disclosure
    Brett MacFarlane Laryngopharyngeal reflux and chronic cough A therapeutic dilemma 1 Disclosure I have received honoraria, speaker fees, consultancy fees, travel support, am a member of advisory boards or have appeared on expert panels for: Reckitt Benkiser, Bayer, Blackmores Produce education material for AJP, Retail Pharmacy, ITK, ACP 2 Disclaimer The information contained herein has not been independently verified, confirmed, reviewed or endorsed by Reckitt Benckiser. No consideration, in any form, has been provided or promised by Reckitt Benckiser in connection with or arising out of this presentation, and all findings are based on my own independent research, experience and expert opinion. The information contained herein is for guidance only and pharmacists are encouraged to conduct their own enquiries. No representation warranty, express or implied, is made as to the accuracy, reliability or correctness of the information contained herein and all liability is disclaimed arising out of or in connection with any reliance on this presentation or the information contained herein. 3 Learning objectives After completing this activity, pharmacists should be able to: 1. Describe laryngopharyngeal reflux (LPR) and how it relates to chronic cough 2. Describe the challenges of diagnosing LPR 3. Outline the management of LPR 4 What does reflux mean to you? Heartburn Acid Burning Rising into the oesophagus 5 What does chronic cough mean to you? Respiratory Asthma COPD Infection Smoking Cancer 6 Reflux is more than just acid Refluxate also contains: Pepsin (stomach) Trypsin (duodenum) Bile salts 7 Causes of chronic cough 29% asthma 33% reflux Li X, et al. Gastroesophageal Reflux Disease and Chronic Cough: A Possible Mechanism Elucidated by Ambulatory pH‐impedance‐pressure Monitoring.
    [Show full text]
  • GERD and Coughing, What PIDD Patients Need to Know
    By Dharshini Mahadevan, MPH While the cause of GERD is not or many with primary immune deficiency disease (PIDD), a chronic cough is nothing new. According to Annette known, the symptoms and what F Zampelli, MSN, CRNP, a medical science liaison for CSL they trigger in PIDD patients can Behring, as well as a former clinician in the Pediatric, Allergy and Immunology Department at Penn State Children’s Hospital, a often be controlled with lifestyle potential culprit of their cough—gastroesophageal reflux disease and dietary changes. (GERD)—is often overlooked. “A lot of people think they’re just having sinus drainage,” said Zampelli, who also suffers from GERD, as well as common variable immune deficiency (CVID). “Or, they may blame coughing on asthma.” Because Zampelli deals with GERD herself, she can often immediately recognize it in others. She recalls one incident during which she realized an individual was refluxing within minutes of meeting her. “A lot of people have chronic hoarseness and intermittent coughing because GERD can cause a laryngeal spasm,” explains Zampelli. “It also causes inflammation of the vocal While the exact cause of cords, which causes them to spasm and leads to irritation to the surrounding tissues.” GERD remains unknown, To determine whether GERD is a factor in one’s cough, Zampelli recommends that patients pay attention to whether many believe hiatal hernias they wake up with morning hoarseness, if they seem to cough more after they lie down or if certain foods make their are a main cause. symptoms worse. In addition, Zampelli suggests that patients track symptoms by using “a food diary to see if there’s any correlation with certain things.
    [Show full text]
  • Cough Hypersensitivity in Patients with Obstructive Sleep Apnea Hypopnea Syndrome
    Sleep and Breathing (2019) 23:33–39 https://doi.org/10.1007/s11325-018-1641-7 SLEEP BREATHING PHYSIOLOGY AND DISORDERS • ORIGINAL ARTICLE Cough hypersensitivity in patients with obstructive sleep apnea hypopnea syndrome Cuiqin Shi1 & Siwei Liang1 & Xianghuai Xu1 & Qiang Chen1 & Lan Wang1 & Li Yu1 & Hanjing Lv 1 & Zhongmin Qiu1 Received: 24 May 2017 /Revised: 5 February 2018 /Accepted: 6 February 2018 /Published online: 16 February 2018 # Springer International Publishing AG, part of Springer Nature 2018 Abstract Purpose The purpose of this study was to investigate cough hypersensitivity and its potential mechanisms in patients with obstructive sleep apnea hypopnea syndrome (OSAHS). Methods Fifteen OSAHS patients, 12 simple snoring patients, and 15 healthy volunteers received cough sensitivity test and induced sputum cytology. Cough thresholds C2 and C5 (the minimum of capsaicin inducing ≥ 2and≥ 5 coughs, respectively), total cell count, cell differentials and the levels of bradykinin, histamine, prostaglandin E2, substance P, calcitonin gene-related peptide, pepsin, and interleukin-2 in the induced sputum detected by enzyme-linked immunosorbent assay were compared. The linear correlation between lgC2 and lgC5 and apnea hypopnea index, cell differentials, and inflammatory mediators in the induced sputum was calculated in OSAHS patients. Results OSAHS patients presented with a significant lower C2 and C5 (P < 0.01), increased lymphocyte but decreased macro- phage and neutrophil proportions in the induced sputum (P < 0.01), and higher contents of substance P, calcitonin gene-related peptide and interleukin-2 (P < 0.01) but similar levels of bradykinin, pepsin, prostaglandin E2, and histamine (P > 0.05) in the supernatant of induced sputum, when compared with simple snoring patients and healthy volunteers.
    [Show full text]
  • Approach to Chronic Cough and Atopy Year 3 Clerkship Guide, Family Medicine Department Schulich School of Medicine and Dentistry ______Objectives 1
    Approach to Chronic Cough and Atopy Year 3 Clerkship Guide, Family Medicine Department Schulich School of Medicine and Dentistry _____________________________________________________________________________________________ Objectives 1. Understand the principles of management for allergic conditions 2. Be able to conduct an appropriate history and physical exam for someone with a complaint of chronic cough. 3. Be able to outline a differential diagnosis for chronic cough. 4. Identify appropriate investigations for a child complaining of chronic cough. 5. Develop an approach for management of asthma. 6. Be able to distinguish between seborrheic dermatitis and atopic dermatitis. 7. Be able to identify other atopic conditions (allergic rhinitis and atopic dermatitis), order appropriate investigations for diagnosis and outline a plan for management. 8. Understand the correct management for an acute exacerbation of asthma. 9. Be able to explain and demonstrate when and how to use a puffer (see module) 10. Atopy refers to a genetic predisposition to the type 1 hypersensitivity reactions that most commonly manifest as allergic rhinitis, asthma, and atopic dermatitis. Approach to Chronic Cough History: When taking a history, make sure to identify the onset and nature of the cough, including whether it is productive, if there is associated dyspnea, what the cough sounds like and if there are any other symptoms (e.g. rhinorrhea, allodynia, malaise, headache, or fever) which might indicate an infectious cause. Determine what the circumstances were at the onset of the cough, as a cough that onset while playing or eating may lead to suspicion about a foreign body in the airway. Ask about any medications that may have been taken to control the cough and whether they were effective.
    [Show full text]
  • Cystic Fibrosis
    cf_new3.qxd 2/21/96 3:14 PM Page 1 FACTS ABOUT Cystic Fibrosis What Is Cystic Fibrosis What Are the Signs and Symptoms Cystic fibrosis (CF) is a chronic, progressive, of CF? and frequently fatal genetic (inherited) dis­ CF does not follow the same pattern in all ease of the body’s mucus glands. CF pri­ patients but affects different people in dif­ marily affects the respiratory and digestive ferent ways and to varying degrees. systems in children and young adults. The However, the basic problem is the same— sweat glands and the reproductive system an abnormality in the glands, which pro­ are also usually involved. On the average, duce or secrete sweat and mucus. Sweat individuals with CF have a lifespan of cools the body; mucus lubricates the respi­ approximately 30 years. ratory, digestive, and reproductive systems, and prevents tissues from drying out, pro­ CF-like disease has been known for over tecting them from infection. two centuries. The name, cystic fibrosis of the pancreas, was first applied to the disease People with CF lose excessive amounts of in 1938. salt when they sweat. This can upset the balance of minerals in the blood, which may How Common Is CF? cause abnormal heart rhythms. Going into shock is also a risk. According to the data collected by the Cystic Fibrosis Foundation, there are about Mucus in CF patients is very thick and 30,000 Americans, 3,000 Canadians, and accumulates in the intestines and lungs. 20,000 Europeans with CF. The disease The result is malnutrition, poor growth, occurs mostly in whites whose ancestors frequent respiratory infections, breathing came from northern Europe, although it difficulties, and eventually permanent lung affects all races and ethnic groups.
    [Show full text]
  • Chronic Cough: Evaluation and Management CHARLIE MICHAUDET, MD, and JOHN MALATY, MD, University of Florida College of Medicine, Gainesville, Florida
    Chronic Cough: Evaluation and Management CHARLIE MICHAUDET, MD, and JOHN MALATY, MD, University of Florida College of Medicine, Gainesville, Florida Although chronic cough in adults (cough lasting longer than eight weeks) can be caused by many etiologies, four conditions account for most cases: upper airway cough syndrome, gastroesophageal reflux disease/laryngopharyn- geal reflux disease, asthma, and nonasthmatic eosinophilic bronchitis. Patients should be evaluated clinically (with spirometry, if indicated), and empiric treatment should be initi- ated. Other potential causes include angiotensin-converting enzyme inhibitor use, environmental triggers, tobacco use, chronic obstruc- tive pulmonary disease, and obstructive sleep apnea. Chest radiogra- phy can rule out concerning infectious, inflammatory, and malignant thoracic conditions. Patients with refractory chronic cough may warrant referral to a pulmonologist or otolaryngologist in addi- tion to a trial of gabapentin, pregabalin, and/or speech therapy. In children, cough is considered chronic if present for more than four weeks. In children six to 14 years of age, it is most commonly caused by asthma, protracted bacterial bronchitis, and upper airway cough syndrome. Evaluation should focus initially on these etiologies, with targeted treatment and monitoring for resolution. (Am Fam Physi- cian. 2017;96(9):575-580. Copyright © 2017 American Academy of Family Physicians.) ILLUSTRATION JONATHAN BY DIMES CME This clinical content ough caused by the common cold less than three weeks and subacute cough conforms to AAFP criteria typically lasts one to three weeks from three to eight weeks.2 When persistent for continuing medical education (CME). See and is self-limited. However, per- and excessive, cough can seriously impair CME Quiz on page 567.
    [Show full text]
  • ERS Guidelines on the Diagnosis and Treatment of Chronic Cough in Adults and Children
    ERS OFFICIAL DOCUMENT ERS GUIDELINES ERS guidelines on the diagnosis and treatment of chronic cough in adults and children Alyn H. Morice1, Eva Millqvist2, Kristina Bieksiene3, Surinder S. Birring4,5, Peter Dicpinigaitis6, Christian Domingo Ribas7, Michele Hilton Boon 8, Ahmad Kantar 9, Kefang Lai10,21, Lorcan McGarvey11, David Rigau12, Imran Satia13,14, Jacky Smith15, Woo-Jung Song 16,22, Thomy Tonia17, Jan W. K. van den Berg18, Mirjam J.G. van Manen19 and Angela Zacharasiewicz20 @ERSpublications New ERS guideline on chronic cough details the paradigm shift in our understanding. In adults, cough hypersensitivity has become the overarching diagnosis, and in children, persistent bacterial bronchitis explains most wet cough, changing treatment advice. http://bit.ly/2kycX8D Cite this article as: Morice AH, Millqvist E, Bieksiene K, et al. ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J 2020; 55: 1901136 [https://doi.org/10.1183/ 13993003.01136-2019]. ABSTRACT These guidelines incorporate the recent advances in chronic cough pathophysiology, diagnosis and treatment. The concept of cough hypersensitivity has allowed an umbrella term that explains the exquisite sensitivity of patients to external stimuli such a cold air, perfumes, smoke and bleach. Thus, adults with chronic cough now have a firm physical explanation for their symptoms based on vagal afferent hypersensitivity. Different treatable traits exist with cough variant asthma (CVA)/eosinophilic bronchitis responding to anti-inflammatory treatment and non-acid reflux being treated with promotility agents rather the anti-acid drugs. An alternative antitussive strategy is to reduce hypersensitivity by neuromodulation. Low-dose morphine is highly effective in a subset of patients with cough resistant to other treatments.
    [Show full text]
  • Utility of Continuous Positive Airway Pressure Therapy for Treating Chronic Coughs in Patients with Obstructive Sleep Apnea
    □ CASE REPORT □ Utility of Continuous Positive Airway Pressure Therapy for Treating Chronic Coughs in Patients with Obstructive Sleep Apnea Naoko Yokohori, Mizue Hasegawa, Akitoshi Sato and Hideki Katsura Abstract We experienced two patients with chronic coughs whose symptoms persisted after initial treatment under a diagnosis of suspected upper airway cough syndrome or cough variant asthma. Neither patient exhibited day- time somnolence, although both were subsequently found to have severe obstructive sleep apnea. Following the administration of nocturnal continuous positive airway pressure therapy, the cough symptoms rapidly im- proved in both cases. These cases represent the first reports of obstructive sleep apnea-induced chronic cough in Japan. Key words: chronic cough, obstructive sleep apnea, continuous positive airway pressure therapy (Intern Med 53: 1079-1082, 2014) (DOI: 10.2169/internalmedicine.53.1855) ports of OSA-induced chronic cough in Japan. Introduction Case Reports The most common causes of chronic coughs in non- smokers with normal chest radiography and pulmonary Case 1 function test findings include cough variant asthma (CVA), gastroesophageal reflux disease (GERD), upper airway A 63-year-old non-smoking woman presented to her pri- cough syndrome (UACS), post-nasal drip syndrome (PNDS), mary care physician due to a dry cough that had persisted chronic bronchitis and the use of angiotensin-converting en- for several years. The primary care physician prescribed zyme (ACE) inhibitors (1, 2). Although the current diagnos- treatment with an inhaled corticosteroid (ciclesonide), two tic and treatment guidelines for chronic cough attempt to different long-acting β2-agonist/inhaled corticosteroid com- rule out such conditions, a significant proportion of chronic binations (salmeterol/fluticasone and formoterol/budesonide), coughs remain unexplained (3, 4).
    [Show full text]
  • ERS Guidelines on the Diagnosis and Treatment of Chronic Cough in Adults and Children
    Early View Task Force Report ERS guidelines on the diagnosis and treatment of chronic cough in adults and children Alyn H. Morice, Eva Millqvist, Kristina Bieksiene, Surinder S. Birring, Peter Dicpinigaitis, Christian Domingo Ribas, Michele Hilton Boon, Ahmad Kantar, Kefang Lai, Lorcan McGarvey, David Rigau, Imran Satia, Jacky Smith, Woo-Jung Song, Thomy Tonia, Jan W. K. van den Berg, Mirjam J. G. van Manen, Angela Zacharasiewicz Please cite this article as: Morice AH, Millqvist E, Bieksiene K, et al. ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J 2019; in press (https://doi.org/10.1183/13993003.01136-2019). This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Copyright ©ERS 2019 ERS guidelines on the diagnosis and treatment of chronic cough in adults and children Alyn H Morice1, Eva Millqvist2, Kristina Bieksiene3, Surinder S Birring4, Peter Dicpinigaitis5, Christian Domingo Ribas6, Michele Hilton Boon7, Ahmad Kantar8, Kefang Lai9*, Lorcan McGarvey10, David Rigau11, Imran Satia12, Jacky Smith13, Woo- Jung Song14**, Thomy Tonia15, Jan WK van den Berg16, Mirjam J. G. van Manen17, Angela Zacharasiewicz18 Affiliations: 1Respiratory Research Group, Hull York Medical School, University of Hull, UK. 2University of Gothenburg, Department of Internal Medicine/Respiratory Medicine and Allergology, Sahlgrenska University Hospital, Sweden. 3Department of Pulmonology, Lithuanian University of Health Sciences, Lithuania.
    [Show full text]
  • ACR Appropriateness Criteria: Chronic Cough
    New 2021 American College of Radiology ACR Appropriateness Criteria® Chronic Cough Variant 1: Chronic cough lasting more than 8 weeks. No known risk factors for lung cancer. Initial imaging. Procedure Appropriateness Category Relative Radiation Level Radiography chest Usually Appropriate ☢ CT chest with IV contrast May Be Appropriate ☢☢☢ CT chest without IV contrast May Be Appropriate ☢☢☢ MRI chest without and with IV contrast Usually Not Appropriate O MRI chest without IV Contrast Usually Not Appropriate O CT chest without and with IV contrast Usually Not Appropriate ☢☢☢ FDG-PET/CT skull base to mid-thigh Usually Not Appropriate ☢☢☢☢ Variant 2: Chronic cough lasting more than 8 weeks. Increased risk for lung cancer. Initial imaging. Procedure Appropriateness Category Relative Radiation Level Radiography chest Usually Appropriate ☢ CT chest with IV contrast May Be Appropriate ☢☢☢ CT chest without IV contrast May Be Appropriate ☢☢☢ MRI chest without and with IV contrast Usually Not Appropriate O MRI chest without IV Contrast Usually Not Appropriate O CT chest without and with IV contrast Usually Not Appropriate ☢☢☢ FDG-PET/CT skull base to mid-thigh Usually Not Appropriate ☢☢☢☢ ACR Appropriateness Criteria® 1 Chronic Cough Variant 3: Chronic cough lasting more than 8 weeks. Persistent symptoms despite initial clinical evaluation and empiric treatment. Initial imaging. Procedure Appropriateness Category Relative Radiation Level Radiography chest Usually Appropriate ☢ CT chest with IV contrast Usually Appropriate ☢☢☢ CT chest without IV
    [Show full text]
  • Coughing Is Normal and It Is How the Body Gets Irritants Or Excess Mucus out of the Lungs
    Occasional coughing is normal and it is how the body gets irritants or excess mucus out of the lungs. But persistent coughing can be a signal of something more serious. Cough What Is a Cough? A cough is a reflex that your body uses to clear your airways of mucus and/or other irritants such as dust or smoke. Coughing occurs when the irritant stimulates nerves in your respiratory tract. This sends the cough impulse to your brain which then signals you to inhale deeply and then use the muscles of your abdomen and diaphragm to forcefully push air from your lungs to expel the irritant. Coughs may either be “productive” or “dry." A productive cough is one that brings up mucus. Dry coughs do not produce anything. A cough can be voluntary, letting you control when you cough, or involuntary. You may also cough repeatedly. Occasional coughing is normal. However, a cough that does not go away within several weeks or one that produces bloody mucus may indicate an underlying condition that requires medical attention. A cough itself rarely requires emergency care, but a very severe bout of coughing can break a rib or cause other injury to the chest or abdomen. Completely suppressing a cough can be bad. If you need to cough but cannot, mucus can build up in the lungs, interfering with breathing and leading to infection and pneumonia. 2013 ©Alere Analytics Proprietary Page 1 of 6 Cough Patient Education What Causes a Cough? Most coughs are caused by viral or bacterial infections and clear up on their own.
    [Show full text]
  • Diagnosis and Management of Chronic Persistent Dry Cough
    Postgrad Med J 1996; 72: 594- 598 (© The Fellowship of Postgraduate Medicine, 1996 Classic symptoms revisited Postgrad Med J: first published as 10.1136/pgmj.72.852.594 on 1 October 1996. Downloaded from Diagnosis and management of chronic persistent dry cough KF Chung, UG Lalloo Summary Cough is a common symptom of most respiratory disorders and is a frequent Cough is one of the commonest reason for patients of all ages to consult their doctor. Chronic cough has been symptoms of lung disease and is a estimated to occur in 14-23% of nonsmoking adults in the US,"2 where it frequent problem encountered in appears to be the fifth most common symptom to be seen in outpatient clinics.3 general practice as well as in One of the recognised functions of cough is to clear excessive secretions from hospital practice. A wide range of the respiratory tract and, as such, it is a useful protective reflex. Persistent cough disease processes may present also occurs in the absence of excessive mucus production and could be with cough and definitive treat- triggered by the presence of a tumour or foreign body. Often, there is no visible ment depends on making an ac- trigger but the presence of a heightened cough sensitivity. In the latter category, curate diagnosis of the cause. A one can include viral upper respiratory tract infections, some patients with diagnostic work-up for patients asthma, post-nasal drip and gastro-oesophageal reflux. The differential with persistent dry cough is diagnosis of chronic cough is extensive and includes infections, inflammatory presented.
    [Show full text]